deferiprone has been researched along with Memory Disorders in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Memory Disorders: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Deferiprone (DFP) is an oral iron chelator used for the treatment of systemic iron overload disorders, and has recently been tested for Parkinson's disease." | 1.48 | Iron chelator deferiprone rescues memory deficits, hippocampal BDNF levels and antioxidant defenses in an experimental model of memory impairment. ( Alcalde, LA; Bogo, MR; de Freitas Crivelaro, PC; de Freitas, BS; Dornelles, VC; Gus, H; Kist, LW; Machado, GDB; Monteiro, RT; Schröder, N, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fawzi, SF | 1 |
| Menze, ET | 1 |
| Tadros, MG | 1 |
| Alcalde, LA | 1 |
| de Freitas, BS | 1 |
| Machado, GDB | 1 |
| de Freitas Crivelaro, PC | 1 |
| Dornelles, VC | 1 |
| Gus, H | 1 |
| Monteiro, RT | 1 |
| Kist, LW | 1 |
| Bogo, MR | 1 |
| Schröder, N | 1 |
2 other studies available for deferiprone and Memory Disorders
| Article | Year |
|---|---|
Deferiprone ameliorates memory impairment in Scopolamine-treated rats: The impact of its iron-chelating effect on β-amyloid disposition.
Topics: Amyloid beta-Peptides; Animals; Behavior, Animal; Cholinergic Antagonists; Deferiprone; Iron; Iron C | 2020 |
Iron chelator deferiprone rescues memory deficits, hippocampal BDNF levels and antioxidant defenses in an experimental model of memory impairment.
Topics: Animals; Antioxidants; Brain-Derived Neurotrophic Factor; Deferiprone; Disease Models, Animal; Femal | 2018 |